Toning down the 2019-nCoV media hype-and restoring hope

Affiliations

¹ Lazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
² Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
³ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo.
⁴ Champalimaud Centre for the Unknown, Lisbon, Portugal and I Med Clinic, University of Mainz, Germany.
⁵ Department of Infection, Division of Infection and Immunity, University College London, and National Institutes of Health and Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: a.zumla@ucl.ac.uk.

Comment

Giuseppe Ippolito et al. Lancet Respir Med. 2020 Mar.

. 2020 Mar;8(3):230-231.

doi: 10.1016/S2213-2600(20)30070-9. Epub 2020 Feb 12.

¹ Lazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
² Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
³ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo.
⁴ Champalimaud Centre for the Unknown, Lisbon, Portugal and I Med Clinic, University of Mainz, Germany.
⁵ Department of Infection, Division of Infection and Immunity, University College London, and National Institutes of Health and Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: a.zumla@ucl.ac.uk.

No abstract available

Figures

Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread.
McCloskey B, Dar O, Zumla A, Heymann DL. McCloskey B, et al. Lancet Infect Dis. 2014 Oct;14(10):1001-10. doi: 10.1016/S1473-3099(14)70846-1. Epub 2014 Sep 1. Lancet Infect Dis. 2014. PMID: 25189351 Free PMC article. Review.

1. McCloskey B, Dar O, Zumla A, Heymann DL. Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread. Lancet Infect Dis. 2014;14:1001–1010. - PMC - PubMed
1. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. Infez Med. 2020;28:3–5. - PubMed
1. Hui DS, Azhar EI, Madani TA. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. - PMC - PubMed
1. McCloskey B, Heymann DL. SARS to novel coronaviruses—old lessons and new lessons. Epidemiology Infection. 2020;148:E22. - PMC - PubMed
1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 coronavirus in Wuhan, China. Lancet. 2020 doi: 10.1016/S0140-6736(20)30183-5. published online Jan 24. - DOI - PMC - PubMed